home / stock / oxfd / oxfd quote
Last: | $21.99 |
---|---|
Change Percent: | 0.05% |
Open: | $21.97 |
Close: | $21.99 |
High: | $21.99 |
Low: | $21.97 |
Volume: | 808,562 |
Last Trade Date Time: | 03/05/2021 04:55:48 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.99 | $21.97 | $21.99 | $21.99 | $21.97 | 808,562 | 03-05-2021 |
$21.98 | $21.97 | $21.98 | $21.99 | $21.965 | 562,600 | 03-04-2021 |
$21.97 | $22 | $21.97 | $22 | $21.96 | 898,824 | 03-03-2021 |
$21.97 | $21.98 | $21.97 | $21.985 | $21.95 | 1,004,949 | 03-02-2021 |
$21.96 | $21.97 | $21.96 | $22 | $21.96 | 174,332 | 03-01-2021 |
$21.95 | $21.99 | $21.95 | $21.99 | $21.93 | 339,261 | 02-26-2021 |
$21.92 | $21.98 | $21.92 | $21.98 | $21.9 | 208,874 | 02-25-2021 |
$21.93 | $21.91 | $21.93 | $21.96 | $21.88 | 490,479 | 02-24-2021 |
$21.88 | $21.96 | $21.88 | $21.96 | $21.85 | 883,044 | 02-23-2021 |
$21.95 | $21.94 | $21.95 | $21.96 | $21.84 | 313,806 | 02-22-2021 |
$21.94 | $21.95 | $21.94 | $21.96 | $21.94 | 246,867 | 02-19-2021 |
$21.95 | $21.94 | $21.95 | $21.96 | $21.94 | 120,807 | 02-18-2021 |
$21.95 | $21.93 | $21.95 | $21.97 | $21.93 | 203,811 | 02-17-2021 |
$21.96 | $21.95 | $21.96 | $22 | $21.92 | 154,299 | 02-16-2021 |
$21.94 | $21.91 | $21.94 | $21.99 | $21.91 | 252,439 | 02-15-2021 |
$21.94 | $21.91 | $21.94 | $21.99 | $21.91 | 252,439 | 02-12-2021 |
$21.92 | $21.96 | $21.92 | $22.02 | $21.92 | 145,228 | 02-11-2021 |
$21.94 | $22 | $21.94 | $22.005 | $21.92 | 185,143 | 02-10-2021 |
$21.95 | $21.95 | $21.95 | $22 | $21.94 | 187,077 | 02-09-2021 |
$21.92 | $21.99 | $21.92 | $22 | $21.9 | 106,710 | 02-08-2021 |
News, Short Squeeze, Breakout and More Instantly...
Oxford Immunotec Global PLC Company Name:
OXFD Stock Symbol:
NASDAQ Market:
Oxford Immunotec Global PLC Website:
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection Canada NewsWire OXFORD , United Kingdom and MARLBOROUGH, Ma...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces it has worked with GC MS and MESDIA Co., Ltd. to enter into an MOU to market t...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit. Th...